No abstract available
MeSH terms
-
Aged
-
Antibodies, Monoclonal, Humanized* / adverse effects
-
Antibodies, Monoclonal, Humanized* / therapeutic use
-
Antineoplastic Agents, Immunological* / adverse effects
-
Fatal Outcome
-
Female
-
Humans
-
Liver Neoplasms* / drug therapy
-
Liver Neoplasms* / secondary
-
Male
-
Melanoma* / drug therapy
-
Melanoma* / pathology
-
Melanoma* / secondary
-
Melanoma, Cutaneous Malignant
-
Middle Aged
-
Rupture, Spontaneous / chemically induced
-
Skin Neoplasms* / drug therapy
-
Skin Neoplasms* / pathology
Substances
-
pembrolizumab
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological